MK0364

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0364, covering 2015-04-03 to 2015-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0364 in Obese Patients (0364-014) [Phase 3]